Ocrevus:Genentech

Genentech

Genentech

OCREVUSisapprovedbytheFDAtotreatrelapsingorprimaryprogressiveformsofmultiplesclerosis(MS).OCREVUSisgivenonceeverysixmonthsbyan ...。其他文章還包含有:「Ocrelizumab」、「Ocrelizumab(Ocrevus)」、「Ocrevus(ocrelizumab)」、「OCREVUS®(ocrelizumab)」、「RelapsingMSandPrimaryProgressive...」、「RelapsingMSandPrimaryProgressiveMSTreatment...」、「Roche多發性硬化症藥物Ocrevus追蹤試驗,針對孕婦族群...」...

查看更多 離開網站

Provide From Google
Ocrelizumab
Ocrelizumab

https://en.wikipedia.org

Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody.

Provide From Google
Ocrelizumab (Ocrevus)
Ocrelizumab (Ocrevus)

https://www.mssociety.org.uk

Ocrelizumab is a disease modifying therapy (DMT) for active relapsing MS or early primary progressive MS. Its brand name is Ocrevus and you take it as an ...

Provide From Google
Ocrevus (ocrelizumab)
Ocrevus (ocrelizumab)

https://www.roche.com

Ocrevus is a medicine that represents a different scientific approach to treating multiple sclerosis. It targets a type of immune cell called the ...

Provide From Google
OCREVUS® (ocrelizumab)
OCREVUS® (ocrelizumab)

https://www.ocrevus.com

Learn about OCREVUS® (ocrelizumab), a prescription medicine used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive ...

Provide From Google
Relapsing MS and Primary Progressive ...
Relapsing MS and Primary Progressive ...

https://www.ocrevus.com

Discover how OCREVUS® (ocrelizumab) may help treat relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS).

Provide From Google
Relapsing MS and Primary Progressive MS Treatment ...
Relapsing MS and Primary Progressive MS Treatment ...

https://www.ocrevus-hcp.com

OCREVUS® (ocrelizumab) is a prescription medicine used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive multiple ...

Provide From Google
Roche 多發性硬化症藥物Ocrevus 追蹤試驗,針對孕婦族群 ...
Roche 多發性硬化症藥物Ocrevus 追蹤試驗,針對孕婦族群 ...

https://geneonline.news

Ocrevus 是第一個、也是目前唯一批准用於復發型多發性硬化症(relapsing mulriple sclerosis, RMS)與原發進展型多發性硬化症(primary progressive multiple ...

Provide From Google
羅氏多發性硬化症新藥Ocrevus將2017年上市
羅氏多發性硬化症新藥Ocrevus將2017年上市

https://ibmi.taiwan-healthcare

ocrelizumab是一種靜脈輸注藥物,6個月輸注一次,每年只需輸注2次,有望顯著改善MS患者的依從性。如果獲批,羅氏計劃于2017年將Ocrevus推向市場,用于PPMS和RMS ...

最新搜尋趨勢